These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36298748)

  • 21. Characterising Non-Structural Protein NS4 of African Horse Sickness Virus.
    Zwart L; Potgieter CA; Clift SJ; van Staden V
    PLoS One; 2015; 10(4):e0124281. PubMed ID: 25915516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative ultrastructural characterization of African horse sickness virus-infected mammalian and insect cells reveals a novel potential virus release mechanism from insect cells.
    Venter E; van der Merwe CF; Buys AV; Huismans H; van Staden V
    J Gen Virol; 2014 Mar; 95(Pt 3):642-651. PubMed ID: 24347494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation of recombinant African horse sickness virus VP7 antigen via a simple method and validation of a VP7-based indirect ELISA for the detection of group-specific IgG antibodies in horse sera.
    Maree S; Paweska JT
    J Virol Methods; 2005 Apr; 125(1):55-65. PubMed ID: 15737417
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.
    Basak AK; Gouet P; Grimes J; Roy P; Stuart D
    J Virol; 1996 Jun; 70(6):3797-806. PubMed ID: 8648715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recovery of African horse sickness virus from synthetic RNA.
    Kaname Y; Celma CCP; Kanai Y; Roy P
    J Gen Virol; 2013 Oct; 94(Pt 10):2259-2265. PubMed ID: 23860489
    [TBL] [Abstract][Full Text] [Related]  

  • 26. African horse sickness outbreaks caused by multiple virus types in Ethiopia.
    Aklilu N; Batten C; Gelaye E; Jenberie S; Ayelet G; Wilson A; Belay A; Asfaw Y; Oura C; Maan S; Bachanek-Bankowska K; Mertens PP
    Transbound Emerg Dis; 2014 Apr; 61(2):185-92. PubMed ID: 23083078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of two trapping methods for Culicoides biting midges and determination of African horse sickness virus prevalence in midge populations at Onderstepoort, South Africa.
    Scheffer EG; Venter GJ; Labuschagne K; Page PC; Mullens BA; MacLachlan NJ; Osterrieder N; Guthrie AJ
    Vet Parasitol; 2012 Apr; 185(2-4):265-73. PubMed ID: 22014560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
    Williams CF; Inoue T; Lucus AM; Zanotto PM; Roy P
    Virus Res; 1998 Jan; 53(1):53-73. PubMed ID: 9617769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of African horse sickness virus VP7 protein expression in cultured cells by RNA interference.
    Stassen L; Huismans H; Theron J
    Virus Genes; 2007 Dec; 35(3):777-83. PubMed ID: 17851744
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with recombinant Modified Vaccinia Ankara (MVA) viruses expressing single African horse sickness virus VP2 antigens induced cross-reactive virus neutralising antibodies (VNAb) in horses when administered in combination.
    Manning NM; Bachanek-Bankowska K; Mertens PPC; Castillo-Olivares J
    Vaccine; 2017 Oct; 35(44):6024-6029. PubMed ID: 28438410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
    Chiam R; Sharp E; Maan S; Rao S; Mertens P; Blacklaws B; Davis-Poynter N; Wood J; Castillo-Olivares J
    PLoS One; 2009 Jun; 4(6):e5997. PubMed ID: 19543394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of monoclonal antibodies binding to the VP7 protein of African horse sickness virus.
    Luciani M; Armillotta G; Ciarelli A; Ulisse S; Teodori L; Bortone G; Giamboi A; Monaco F; Tittarelli M; Di Ventura M; Iannetti L; Podaliri Vulpiani M; Di Febo T
    J Virol Methods; 2019 Aug; 270():131-136. PubMed ID: 31095974
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural insight into African horsesickness virus infection.
    Manole V; Laurinmäki P; Van Wyngaardt W; Potgieter CA; Wright IM; Venter GJ; van Dijk AA; Sewell BT; Butcher SJ
    J Virol; 2012 Aug; 86(15):7858-66. PubMed ID: 22593166
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
    Calvo-Pinilla E; Gubbins S; Mertens P; Ortego J; Castillo-Olivares J
    Antiviral Res; 2018 Jun; 154():132-139. PubMed ID: 29678552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of Orbivirus Replication by Aurintricarboxylic Acid.
    Alonso C; Utrilla-Trigo S; Calvo-Pinilla E; Jiménez-Cabello L; Ortego J; Nogales A
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness.
    Rutkowska DA; Mokoena NB; Tsekoa TL; Dibakwane VS; O'Kennedy MM
    BMC Vet Res; 2019 Dec; 15(1):432. PubMed ID: 31796116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular epidemiology of African horse sickness virus based on analyses and comparisons of genome segments 7 and 10.
    Zientara S; Sailleau C; Plateau E; Moulay S; Mertens PP; Crucière C
    Arch Virol Suppl; 1998; 14():221-34. PubMed ID: 9785509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and optimisation of a duplex real-time reverse transcription quantitative PCR assay targeting the VP7 and NS2 genes of African horse sickness virus.
    Quan M; Lourens CW; MacLachlan NJ; Gardner IA; Guthrie AJ
    J Virol Methods; 2010 Jul; 167(1):45-52. PubMed ID: 20304015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The transmission and geographical spread of African horse sickness and bluetongue viruses.
    Mellor PS; Boorman J
    Ann Trop Med Parasitol; 1995 Feb; 89(1):1-15. PubMed ID: 7741589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.